Katsuiku Hirokawa
Direktor/Vorstandsmitglied bei Institute For Health &Life Science
Aktive Positionen von Katsuiku Hirokawa
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Institute For Health &Life Science | Direktor/Vorstandsmitglied | 01.05.2006 | - |
Karriereverlauf von Katsuiku Hirokawa
Ehemalige bekannte Positionen von Katsuiku Hirokawa
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TELLA, INC. | Direktor/Vorstandsmitglied | 27.03.2019 | - |
| Independent Dir/Board Member | 27.03.2019 | - |
Statistik
International
| Japan | 3 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Institute For Health &Life Science | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Börse
- Insiders
- Katsuiku Hirokawa
- Erfahrung
